The Cost effectiveness of a Novel High Priced Combination Therapy for Hepatitis C In Treatment NaÏVe Genotype 1 Infected Patients
Abstract
Authors
J.J. McGinnis J.W. Hay
J.J. McGinnis J.W. Hay
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now